NCT07084701 Effects of Non-Invasive Superficial Craniocervical Lymphatic Drainage (NSCLD) on Memory and Cognitive Function in Adults With Sleep Deprivation: A Proof-of-Concept Study
| NCT ID | NCT07084701 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tao Liu |
| Condition | Sleep Deprivation |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2025-09-15 |
| Primary Completion | 2026-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2025-09-15 with a primary completion date of 2026-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This Effects of Non-Invasive Superficial Craniocervical Lymphatic Drainage (NSCLD) on Memory and Cognitive Function in Adults with Sleep deprivation: A Proof-of-Concept Study aims to investigate the effects of Non-Invasive Superficial Craniocervical Lymphatic Drainage (NSCLD) on memory and cognitive function in adults experiencing sleep deprivation(SD). Given the known impact of SD on cognitive performance, this study seeks to explore whether NSCLD, as a non-invasive intervention, can mitigate the cognitive impairments associated with SD.
Eligibility Criteria
Inclusion Criteria: * College student ≥18 years, all of whom have passed a standardized entrance examination; * No failed exams during the course of study; * Sleep deprivation; * In good health, with no mental or psychological disorders; * No recent use of medications that may affect memory and cognition; * Voluntary participation and able to undergo cognitive function and memory testing; * Informed consent provided Exclusion Criteria: * Pregnant or breastfeeding women. * Presence of acute or chronic medical conditions (e.g., severe hypertension, diabetes, cardiovascular disease) that could confound the results. * History of craniocervical trauma or surgery. * Current use of sedative or anxiolytic medications that could influence sleep or cognitive function. * Participants who are unable to follow the procedures or complete the assessments
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07084701 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Sleep Deprivation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07084701 currently recruiting?
Yes, NCT07084701 is actively recruiting participants. Contact the research team at TLiu1@georgeinstitute.org.au for enrollment information.
Where is the NCT07084701 trial being conducted?
This trial is being conducted at Tianjin, China.
Who is sponsoring the NCT07084701 clinical trial?
NCT07084701 is sponsored by Tao Liu. The trial plans to enroll 30 participants.